Rigel Pharmaceuticals, Inc. - Common Stock (NQ:RIGL)

45.71 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rigel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗

December 02, 2022

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.

Via Benzinga

Why Are Chinese EV Stocks NIO, LI, XPEV Up Today? ↗

December 02, 2022

Chinese EV stocks are charging higher on Friday as investors hold out hope for easing Covid-19 restrictions sometime next year.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 02, 2022

Via Benzinga

Another Clinical Trial Setback For Rigel Pharma's Lead Program, This Time For COVID-19 ↗

November 02, 2022

Via Benzinga

Expert Ratings for Rigel Pharmaceuticals ↗

August 17, 2022

Rigel Pharmaceuticals (NASDAQ:RIGL) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why Are Chinese Stocks BABA, BILI, IQ Up Today? ↗

December 02, 2022

Chinese stocks are climbing higher on Friday as investors continue to hope that the country will ease off of Covid-19 restrictions.

Via InvestorPlace

BBWI Stock Climbs as Bath & Body Works Candle Day Sale Kicks Off ↗

December 02, 2022

Bath & Body Works (BBWI) stock is rising higher on Friday as the retail company starts its annual Candle Day sale with a deep discount.

Via InvestorPlace

Gold Down 1%; Samsara Shares Spike Higher ↗

December 02, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday.

Via Benzinga

Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News ↗

December 02, 2022

Rigel Pharmaceuticals (RIGL) stock is heading higher on Friday after getting approval from the FDA for its leukemia treatment.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 02, 2022

Via Benzinga

Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket ↗

December 02, 2022

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 02, 2022

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!

Via InvestorPlace

Preview: Rigel Pharmaceuticals's Earnings ↗

November 02, 2022

Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel...

Via Benzinga

Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket ↗

November 02, 2022

Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.

Via Benzinga

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday ↗

October 12, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.

Via Benzinga

Nasdaq Drops 150 Points; AZZ Shares Plummet ↗

October 11, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 11, 2022

Gainers

Via Benzinga

Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗

October 11, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939.

Via Benzinga

Dow Surges Over 100 Points; Crude Oil Down 2% ↗

October 11, 2022

U.S. stocks pared some losses midway through trading, with the Dow Jones gaining more than 100 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 11, 2022

Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion.

Via Benzinga

Rigel Pharma Drops FDA Submission Plans For Expanded Use Of Its Lead Product ↗

October 11, 2022

Rigel Pharmaceuticals Inc (NASDAQ: RIGL) received guidance from the FDA's review of its re-analysis of data from the FORWARD Phase 3 trial of fostamatinib for warm autoimmune hemolytic anemia...

Via Benzinga

Why Leggett & Platt Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket ↗

October 11, 2022

Gainers Vox Royalty Corp. (NASDAQ: VOXR) rose 60.4% to $4.33 in pre-market trading. Vox Royalty’s common shares commenced trading on The Nasdaq Stock Market on Monday.

Via Benzinga

iQIYI, Las Vegas Sands And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

October 11, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 10, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.

Via Benzinga

Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗

August 24, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 18, 2022

Via Benzinga

Piper Sandler Maintains Neutral Rating for Rigel Pharmaceuticals: Here's What You Need To Know ↗

August 17, 2022

Piper Sandler has decided to maintain its Neutral rating of Rigel Pharmaceuticals (NASDAQ:RIGL) and raise its price target from $1.00 to $2.00. Shares of Rigel Pharmaceuticals are trading up 1.12%...

Via Benzinga

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗

August 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Rigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pact ↗

August 03, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.